Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice

CompletedOBSERVATIONAL
Enrollment

398

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
HIV Infections
Trial Locations (53)

Unknown

Boehringer Ingelheim Investigational Site 6, Graz

Boehringer Ingelheim Investigational Site 5, Salzburg

Boehringer Ingelheim Investigational Site 1, Vienna

Boehringer Ingelheim Investigational Site 2, Vienna

Boehringer Ingelheim Investigational Site 3, Vienna

Boehringer Ingelheim Investigational Site 4, Wels

Boehringer Ingelheim Investigational Site 7, Bialystok

Boehringer Ingelheim Investigational Site 8, Bialystok

Boehringer Ingelheim Investigational Site 10, Bydgoszcz

Boehringer Ingelheim Investigational Site 9, Bydgoszcz

Boehringer Ingelheim Investigational Site 11, Chorzów

Boehringer Ingelheim Investigational Site 12, Chorzów

Boehringer Ingelheim Investigational Site 13, Gdañsk

Boehringer Ingelheim Investigational Site 14, Gdañsk

Boehringer Ingelheim Investigational Site 15, Gdañsk

Boehringer Ingelheim Investigational Site 16, Krakow

Boehringer Ingelheim Investigational Site 17, Krakow

Boehringer Ingelheim Investigational Site 18, Poznañ

Boehringer Ingelheim Investigational Site 19, Wroc£aw

Boehringer Ingelheim Investigational Site 20, Wroc£aw

Boehringer Ingelheim Investigational Site 50, Bacau

Boehringer Ingelheim Investigational Site 51, Brasov

Boehringer Ingelheim Investigational Site 52, Brasov

Boehringer Ingelheim Investigational Site 53, Brasov

Boehringer Ingelheim Investigational Site 21, Bucharest

Boehringer Ingelheim Investigational Site 22, Bucharest

Boehringer Ingelheim Investigational Site 23, Bucharest

Boehringer Ingelheim Investigational Site 24, Bucharest

Boehringer Ingelheim Investigational Site 25, Bucharest

Boehringer Ingelheim Investigational Site 26, Bucharest

Boehringer Ingelheim Investigational Site 27, Bucharest

Boehringer Ingelheim Investigational Site 28, Bucharest

Boehringer Ingelheim Investigational Site 29, Bucharest

Boehringer Ingelheim Investigational Site 30, Bucharest

Boehringer Ingelheim Investigational Site 31, Bucharest

Boehringer Ingelheim Investigational Site 32, Bucharest

Boehringer Ingelheim Investigational Site 33, Bucharest

Boehringer Ingelheim Investigational Site 34, Bucharest

Boehringer Ingelheim Investigational Site 35, Bucharest

Boehringer Ingelheim Investigational Site 36, Bucharest

Boehringer Ingelheim Investigational Site 37, Bucharest

Boehringer Ingelheim Investigational Site 38, Bucharest

Boehringer Ingelheim Investigational Site 39, Bucharest

Boehringer Ingelheim Investigational Site 40, Bucharest

Boehringer Ingelheim Investigational Site 41, Bucharest

Boehringer Ingelheim Investigational Site 42, Bucharest

Boehringer Ingelheim Investigational Site 43, Bucharest

Boehringer Ingelheim Investigational Site 44, Bucharest

Boehringer Ingelheim Investigational Site 46, Constanța

Boehringer Ingelheim Investigational Site 47, Constanța

Boehringer Ingelheim Investigational Site 48, Constanța

Boehringer Ingelheim Investigational Site 45, Giurgiu

Boehringer Ingelheim Investigational Site 49, Ploieşti

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01524900 - Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice | Biotech Hunter | Biotech Hunter